Clinical trial
PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXED
NCT05142332 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXED
- Lead sponsor
- University of California, San Francisco
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 6, 2021
- Completion date
- August 30, 2022
- Enrollment
- 541 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 vaccine, vaccine hesitancy